Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021

血管ステントの世界市場予測(~2021年):ベアメタルステント、生体吸収性ステント、薬剤溶出ステント

◆タイトル:Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021
◆商品コード:MAM-MD5228
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年5月3日
◆ページ数:191
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、血管ステントの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、製品別分析、材料別分析、需要先別分析、血管ステントの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The vascular stent market is projected to reach USD 17.68 billion by 2021 from USD 12.21 billion in 2016, at a CAGR of 7.7% from 2016 to 2021. The growth of this market is majorly driven by factors such as technological advancements in vascular stents, increasing number of angioplasty procedures, rising burden of vascular diseases, increasing demand for minimally invasive procedures, and rising geriatric population.
On the basis of product, the vascular stent market is segmented into coronary stents, peripheral stents, and EVAR stent grafts. Peripheral stents are further segmented into carotid stents, renal artery stents, femoral stents, iliac stents, and other peripheral stents. EVAR stent grafts are further segmented into abdominal aortic aneurysm and thoracic aortic aneurysm. The coronary stents segment accounted for the largest share of the vascular stent market in 2016. The large share of this segment can primarily be attributed to the rising incidence of coronary artery disease and technological advancements in coronary stents.

On the basis of type, the market is segmented into bare-metal stents, drug-eluting stents, and bioabsorbable stents. The drug-eluting stents segment accounted for the largest share in 2016 primarily due to the advantages these stents offer over bare-metal stents, including lower risk of restenosis and other related complications.

On the basis of mode of delivery, the vascular stent market is segmented into balloon-expandable stents and self-expanding stents. The balloon-expandable stents segment is estimated to register the highest growth during the forecast period due to the growing regulatory approvals for balloon-expandable stents and the increasing number of research activities focusing on improving the balloon-expandable stent technology.

On the basis of material, the market is segmented into metallic stents (cobalt chromium, platinum chromium, nickel titanium, and stainless steel) and other stents. The other stents segment is projected to grow at the highest CAGR during the forecast period. The high growth in this segment is attributed to the growing utilization of polymers and copolymers for the development of bioabsorbable stents.

On the basis of end user, the market is segmented into hospitals & cardiac centers and ambulatory surgical centers. The hospitals & cardiac centers segment dominated this market in 2016 as the majority of patients opt to undergo angioplasty procedures in hospitals, owing to which the demand for vascular stents is higher in this end-user segment.

In 2016, North America was the largest market for vascular stents, followed by Europe. However, the Asian market is expected to grow at the highest CAGR during the forecast period. Factors such as the large population base, growing prevalence of cardiac diseases, rising adoption of advanced technologies, and low manufacturing costs for medical devices in emerging Asian countries are driving the growth of this market.

Key players in the vascular stent market include Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), W. L. Gore and Associates (U.S.), C. R. Bard (U.S.), Endologix, Inc. (U.S.), Lombard Medical Technologies (U.K.), Translumina GmbH (Germany), and JOTEC GmbH (Germany).

【レポートの目次】

1 Introduction (Page No. -19)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. -22)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Industry Insights
2.4 Assumptions for the Study

3 Executive Summary (Page No. -29)

4 Premium Insights (Page No. -33)
4.1 Vascular Stents: Market Overview
4.2 Vascular Stent Market, By Product (2016–2021)
4.3 Vascular Stent Market, By Mode of Delivery (2016 Vs. 2021)
4.4 Market, By Material (2016 Vs. 2021)
4.5 Peripheral Market, By Type (2016)
4.6 Market, By End User (2016 Vs. 2021)
4.7 Geographic Snapshot: Vascular Stent Market

5 Market Overview (Page No. -37)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Innovations In Stenting Technologies
5.2.1.2 Rising Incidence of Vascular Diseases and Subsequent GRoWth In the Number
5.2.1.3 Increasing Preference for Minimally Invasive Procedures
5.2.1.4 Rapid GRoWth In the Geriatric Population
5.2.2 Restraints
5.2.2.1 Availability of Alternative Treatment Methods for Vascular Diseases
5.2.2.2 Product Failures and Recalls
5.2.3 Opportunities
5.2.3.1 Development of Bioresorbable Stents
5.2.3.2 Emerging Markets
5.2.4 Challenges
5.2.4.1 Complications Associated With Stent Implantation
5.2.4.2 Declining Costs of Stents
5.3 Regulatory Landscape
5.4 Product Pipeline

6 Vascular Stent Market, By Type (Page No. -45)
6.1 Introduction
6.2 Drug-Eluting Stents
6.3 Bare-Metal Stents
6.4 Bioabsorbable Stents

7 Vascular Stent Market, By Product (Page No. -53)
7.1 Introduction
7.2 Coronary Stents
7.3 Peripheral Stents
7.3.1 Carotid Artery Stents
7.3.2 Renal Artery Stents
7.3.3 Femoral Artery Stents
7.3.4 Iliac Artery Stents
7.3.5 Other Peripheral Stents
7.4 Evar Stent Grafts
7.4.1 Abdominal Aortic Aneurysm Stents
7.4.2 Thoracic Aortic Aneurysm Stents

8 Vascular Stent Market, By Mode of Delivery (Page No. -67)
8.1 Introduction
8.2 Balloon-Expandable Stents
8.3 Self-Expanding Stents

9 Vascular Stent Market, By Material (Page No. -74)
9.1 Introduction
9.2 Metallic Stents
9.2.1 Cobalt Chromium
9.2.2 Platinum Chromium
9.2.3 Nickel Titanium
9.2.4 Stainless Steel
9.3 Other Stents

10 Vascular Stent Market, By End User (Page No. -84)
10.1 Introduction
10.2 Hospitals and Cardiac Centers
10.3 Ambulatory Surgical Centers

11 Vascular Stent Market, By Region (Page No. -90)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Rest of Europe
11.4 Asia
11.5 Rest of the World

12 Competitive Landscape (Page No. -126)
12.1 Overview
12.2 Market Ranking Analysis, Vascular Stent Market
12.3 Vendor Dive Overview
12.3.1 Vanguards
12.3.2 Dynamic Players
12.3.3 Innovators
12.3.4 Emerging Players
12.4 Business Strategy (for All 25 Players)
12.5 Product offerings (for All 25 Players)

*Top 25 Companies Analyzed for This Study Are – Abbott Laboratories (U.S.), B. Braun Melsungen Ag (Germany), Biosensors International (Singapore), Biotronik Se & Co. Kg (Germany), Boston Scientific Corporation (U.S.), Braile Biomédica (Brazil), C. R. Bard (U.S.), Cook Medical (U.S.), Cordis Corporation (U.S.), Endologix, Inc. (U.S.), Grinm Advanced Materials Co., Ltd (China), Insitu Technologies (U.S.), Jotech Gmbh (Germany), Lifetech Scientific Inc. (China), Lombard Medical (U.K.), Medtronic Plc (Ireland), Meril Life Sciences (India), Microport Scientifc Corporation (China), Orbusneich (Hong Kong), S&G Biotech (South Korea), Stentys S.A. (France), Terumo Corporation (Japan), Translumina Gmbh (Germany), Vascular Concepts (India), and W. L. Gore & Associates (U.S

13 Company Profiles (Page No. -132)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, Mnm Vie
13.1 Introduction
13.2 Medtronic Plc
13.3 Abbott Laboratories
13.4 Boston Scientific Corporation
13.5 Biotronik Se & Co. Kg
13.6 B. Braun Melsungen Ag
13.7 Terumo Corporation
13.8 Microport Scientific Corporation
13.9 Meril Life Sciences Pvt. Ltd.
13.10 Vascular Concepts Limited
13.11 C.R. Bard, Inc.
13.12 W.L. Gore and Associates, Inc.
13.13 Endologix, Inc.
13.14 Lombard Medical
13.15 Translumina Gmbh
13.16 Jotec Gmbh

*Details On Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured In Case of Unlisted Compani
14 Appendix (Page No. -179)
14.1 Insights From Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Introducing Rt: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports
14.7 Author Details

List of Tab (138 Tables)

Table 1 Projected Increase In the Global Population Between 2005 and 2030, By Age
Table 2 Other Important Medical Device Regulations
Table 3 Vascular Stent Market: Pipeline Products
Table 4 Vascular Stent Market Size, By Type, 2014-2021 (USD Million)
Table 5 Commercially Available Drug-Eluting Stents
Table 6 Drug-Eluting Stents Market Size, By Region, 2014-2021 (USD Million)
Table 7 North America: Drug-Eluting Stents Market, By Country, 2014-2021 (USD Million)
Table 8 Europe: Drug-Eluting Stents Market, By Country, 2014-2021 (USD Million)
Table 9 Commercially Available Bare-Metal Stents
Table 10 Bare-Metal Stents Market Size, By Region, 2014-2021 (USD Million)
Table 11 North America: Bare-Metal Stents Market, By Country, 2014-2021 (USD Million)
Table 12 Europe: Bare-Metal Stents Market, By Country, 2014-2021 (USD Million)
Table 13 Bioabsorbable Stents Market Size, By Region, 2014-2021 (USD Million)
Table 14 North America: Bioabsorbable Stents Market, By Country, 2014-2021 (USD Million)
Table 15 Europe: Bioabsorbable Stents Market, By Country, 2014-2021 (USD Million)
Table 16 Vascular Stent Market Size, By Product, 2014-2021 (USD Million)
Table 17 Coronary Stents Market Size, By Region, 2014-2021 (USD Million)
Table 18 Coronary Stents Market Size, By Region, 2014-2021 (Units)
Table 19 North America: Coronary Stents Market Size, By Country, 2014-2021 (USD Million)
Table 20 Europe: Coronary Stents Market Size, By Country, 2014-2021 (USD Million)
Table 21 Global Prevalence of Pad, 2010
Table 22 Peripheral Stents Market Size, By Region, 2014-2021 (USD Million)
Table 23 Peripheral Stents Market Size, By Region, 2014-2021 (Units)
Table 24 North America: Peripheral Stents Market Size, By Country, 2014-2021 (USD Million)
Table 25 Europe: Peripheral Stents Market Size, By Country, 2014-2021 (USD Million)
Table 26 Peripheral Stents Market Size, By Type, 2014-2021 (USD Million)
Table 27 Carotid Artery Stents Market Size, By Region, 2014-2021 (USD Million)
Table 28 Renal Artery Stents Market Size, By Region, 2014-2021 (USD Million)
Table 29 Femoral Artery Stents Market Size, By Region, 2014-2021 (USD Million)
Table 30 Iliac Artery Stents Market Size, By Region, 2014-2021 (USD Million)
Table 31 Other Peripheral Stents Market Size, By Region, 2014-2021 (USD Million)
Table 32 Evar Stent Grafts Market Size, By Region, 2014-2021 (USD Million)
Table 33 Evar Stent Grafts Market Size, By Region, 2014-2021 (No. of Procedures)
Table 34 North America: Evar Stent Grafts Market Size, By Country, 2014-2021 (USD Million)
Table 35 Europe: Evar Stent Grafts Market Size, By Country, 2014-2021 (USD Million)
Table 36 Evar Stent Grafts Market Size, By Type, 2014-2021 (USD Million)
Table 37 Aaa Stents Market Size, By Region, 2014-2021 (USD Million)
Table 38 Global Taa Stents Market Size, By Region, 2014-2021 (USD Million)
Table 39 Vascular Stent Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 40 Commercially Available Balloon-Expandable Vascular Stents
Table 41 Balloon-Expandable Stents Market Size, By Region, 2014–2021 (USD Million)
Table 42 North America: Balloon-Expandable Stents Market Size, By Country, 2014–2021 (USD Million)
Table 43 Europe: Balloon-Expandable Stents Market Size, By Country, 2014–2021 (USD Million)
Table 44 Commercially Available Self-Expanding Stents
Table 45 Self-Expanding Stents Market Size, By Region, 2014–2021 (USD Million)
Table 46 North America: Self-Expanding Stents Market Size, By Country, 2014–2021 (USD Million)
Table 47 Europe: Self-Expanding Stents Market Size, By Country, 2014–2021 (USD Million)
Table 48 Vascular Stent Market Size, By Material, 2014–2021 (USD Million)
Table 49 Metallic Vascular Stent Market Size, By Region, 2014–2021 (USD Million)
Table 50 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 51 Europe: Market Size, By Region, 2014–2021 (USD Million)
Table 52 Metallic Vascular Stent Market Size, By Material, 2014–2021 (USD Million)
Table 53 Commercially Available Cobalt Chromium Vascular Stents
Table 54 Cobalt Chromium Market Size, By Region, 2014–2021 (USD Million)
Table 55 Commercially Available Platinum Chromium Vascular Stents
Table 56 Platinum Chromium Market Size, By Region, 2014–2021 (USD Million)
Table 57 Commercially Available Nickel Titanium Vascular Stents
Table 58 Nickel Titanium Vascular Stent Market Size, By Region, 2014–2021 (USD Million)
Table 59 Commercially Available Stainless Steel Vascular Stents
Table 60 Stainless Steel Market Size, By Region, 2014–2021 (USD Million)
Table 61 Other Commercially Available Vascular Stents
Table 62 Other Market Size, By Region, 2014–2021 (USD Million)
Table 63 North America: Other Vascular Stent Market Size, By Country, 2014–2021 (USD Million)
Table 64 Europe: Other Vascular Stent Market Size, By Region, 2014–2021 (USD Million)
Table 65 Market Size, By End User, 2014-2021 (USD Million)
Table 66 Market Size for Hospitals and Cardiac Centers, By Region, 2014-2021 (USD Million)
Table 67 North America: Vascular Stent Market Size for Hospitals and Cardiac Centers, By Country, 2014-2021 (USD Million)
Table 68 Europe: Market Size for Hospitals and Cardiac Centers, By Country, 2014-2021 (USD Million)
Table 69 Market Size for Ambulatory Surgical Centers, By Region, 2014-2021 (USD Million)
Table 70 North America: Vascular Stent Market Size for Ambulatory Surgical Centers, By Country, 2014-2021 (USD Million)
Table 71 Europe: Market Size for Ambulatory Surgical Centers, By Country, 2014-2021 (USD Million)
Table 72 Market Size, By Region, 2014–2021 (USD Million)
Table 73 North America: Vascular Stent Market Size, By Country, 2014–2021 (USD Million)
Table 74 North America: Vascular Stent Market Size, By Product, 2014–2021 (USD Million)
Table 75 North America: Peripheral Vascular Stent Market Size, By Type, 2014–2021 (USD Million)
Table 76 North America: Evar Stent Grafts Market Size, By Type, 2014–2021 (USD Million)
Table 77 North America: Market Size, By Type, 2014–2021 (USD Million)
Table 78 North America: Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 79 North America: Market Size, By Material, 2014–2021 (USD Million)
Table 80 North America: Metallic Vascular Stents Market Size, By Type, 2014–2021 (USD Million)
Table 81 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 82 U.S.: Vascular Stent Market Size, By Product, 2014–2021 (USD Million)
Table 83 U.S.: Vascular Stent Market Size, By Type, 2014–2021 (USD Million)
Table 84 U.S.: Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 85 U.S.: Market Size, By Material, 2014–2021 (USD Million)
Table 86 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 87 Canada: Vascular Stent Market Size, By Product, 2014–2021 (USD Million)
Table 88 Canada: Vascular Stent Market Size, By Type, 2014–2021 (USD Million)
Table 89 Canada: Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 90 Canada: Market Size, By Material, 2014–2021 (USD Million)
Table 91 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 92 Europe: Vascular Stent Market Size, By Country, 2014–2021 (USD Million)
Table 93 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 94 Europe: Peripheral Vascular Stent Market Size, By Type, 2014–2021 (USD Million)
Table 95 Europe: Evar Stent Grafts Market Size, By Type, 2014–2021 (USD Million)
Table 96 Europe: Market Size, By Type, 2014–2021 (USD Million)
Table 97 Europe: Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 98 Europe: Market Size, By Material, 2014–2021 (USD Million)
Table 99 Europe: Metallic Vascular Stent Market Size, By Type, 2014–2021 (USD Million)
Table 100 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 101 Germany: Vascular Stent Market Size, By Product, 2014–2021 (USD Million)
Table 102 Germany: Market Size, By Type, 2014–2021 (USD Million)
Table 103 Germany: Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 104 Germany: Market Size, By Material, 2014–2021 (USD Million)
Table 105 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 106 France: Vascular Stent Market Size, By Product, 2014–2021 (USD Million)
Table 107 France: Market Size, By Type, 2014–2021 (USD Million)
Table 108 France: Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 109 France: Market Size, By Material, 2014–2021 (USD Million)
Table 110 France: Market Size, By End User, 2014–2021 (USD Million)
Table 111 U.K.: Vascular Stent Market Size, By Product, 2014–2021 (USD Million)
Table 112 U.K.: Market Size, By Type, 2014–2021 (USD Million)
Table 113 U.K.: Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 114 U.K.: Market Size, By Material, 2014–2021 (USD Million)
Table 115 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 116 RoE: Healthcare Expenditure, By Country, 2007 Vs. 2014 (% of Gdp)
Table 117 RoE: Vascular Stent Market Size, By Product, 2014–2021 (USD Million)
Table 118 RoE: Vascular Stent Market Size, By Type, 2014–2021 (USD Million)
Table 119 RoE: Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 120 RoE: Market Size, By Material, 2014–2021 (USD Million)
Table 121 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 122 Asia: Vascular Stent Market Size, By Product, 2014–2021 (USD Million)
Table 123 Asia: Peripheral Vascular Stent Market Size, By Type, 2014–2021 (USD Million)
Table 124 Asia: Evar Stent Grafts Market Size, By Type, 2014–2021 (USD Million)
Table 125 Asia: Vascular Stent Market Size, By Type, 2014–2021 (USD Million)
Table 126 Asia: Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 127 Asia: Market Size, By Material, 2014–2021 (USD Million)
Table 128 Asia: Metallic Vascular Stent Market Size, By Type, 2014–2021 (USD Million)
Table 129 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 130 RoW: Vascular Stent Market Size, By Product, 2014–2021 (USD Million)
Table 131 RoW: Peripheral Vascular Stent Market Size, By Type,2014–2021 (USD Million)
Table 132 RoW: Evar Stent Grafts Market Size, By Type, 2014–2021 (USD Million)
Table 133 RoW: Vascular Stent Market Size, By Type, 2014–2021 (USD Million)
Table 134 RoW: Market Size, By Mode of Delivery, 2014–2021 (USD Million)
Table 135 RoW: Market Size, By Material, 2014–2021 (USD Million)
Table 136 RoW: Metallic Vascular Stent Market Size, By Type, 2014–2021 (USD Million)
Table 137 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 138 Top 3 Players In the Market, 2016

List of Figures (76 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Key Data From Secondary Sources
Figure 7 Key Data From Primary Sources
Figure 8 Drug-Eluting Stents To Dominate the Vascular Stent Market During the forecast Period
Figure 9 Balloon-Expandable Stents To Register the Highest Cagr During the forecast Period
Figure 10 Coronary Stents To Dominate the Vascular Stent Market During the forecast Period
Figure 11 Hospitals and Cardiac Centers form Major End Users of Vascular Stents
Figure 12 North America Dominated the Market In 2016
Figure 13 Rising Burden of Vascular Diseases and Innovations In Stenting Technologies Are Driving the Market GRoWth for Vascular Stents During the forecast Period
Figure 14 Coronary Stents Dominated the Market In 2016
Figure 15 Balloon-Expandable Stents form the Largest Market Segment
Figure 16 Metallic Stents To Dominate the Market During the forecast Period
Figure 17 Carotid Stents To Dominate the Peripheral Vascular Stent Market During the forecast Period
Figure 18 Hospitals and Cardiac Centers formed the Largest End Users In 2016
Figure 19 Asia To Register the Highest Market GRoWth During the forecast Period
Figure 20 Vascular Stent Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Bioabsorbable Stents Segment To GRoW At the Highest Rate During the forecast Period
Figure 22 Asia To GRoW At the Highest Cagr In the Drug-Eluting Stents Market During the forecast Period
Figure 23 Evar Stent Grafts Segment To GRoW At the Highest Rate During the forecast Period
Figure 24 Asia To GRoW At the Highest Cagr In the Peripheral Stents Market During the forecast Period
Figure 25 Balloon-Expandable Stents To Dominate Market From 2016 To 2021
Figure 26 North America To Dominate the Balloon-Expandable Stents Market From 2016 To 2021
Figure 27 Metallic Stents To Dominate the Market During the forecast Period
Figure 28 North America Accounted for the Largest Share In the Metallic Stents Market
Figure 29 Hospitals and Cardiac Centers To Dominate the Vascular Stent Market During the forecast Period
Figure 30 North America To Dominate the Market for Hospitals and Cardiac Centers (2016-2021)
Figure 31 North America Will Continue To Dominate the Global Market In 2021
Figure 32 North America: Market Snapshot
Figure 33 Europe: Market Snapshot
Figure 34 Asia: Market Snapshot
Figure 35 RoW: Market Snapshot
Figure 36 Mnm Dive-Vendor Comparison Matrix
Figure 37 Geographic Revenue Mix of the Top Players In the Vascular Stent Market
Figure 38 Medtronic Plc: Company Snapshot (2016)
Figure 39 Medtronic Plc: Product offering Scorecard
Figure 40 Medtronic Plc: Business Strategy Scorecard
Figure 41 Abbott Laboratories: Company Snapshot (2016)
Figure 42 Abbott Laboratories: Product offering Scorecard
Figure 43 Abbott Laboratories: Business Strategy Scorecard
Figure 44 Boston Scientific Corporation: Company Snapshot (2016)
Figure 45 Boston Scientific Corporation: Product offering Scorecard
Figure 46 Boston Scientific Corporation: Business Strategy Scorecard
Figure 47 Biotronik Se & Co. Kg: Product offering Scorecard
Figure 48 Biotronik Se & Co. Kg: Business Strategy Scorecard
Figure 49 B. Braun Melsungen Ag: Company Snapshot (2016)
Figure 50 B. Braun Melsungen Ag: Product offering Scorecard
Figure 51 B. Braun Melsungen Ag: Business Strategy Scorecard
Figure 52 Terumo Corporation: Company Snapshot (2015)
Figure 53 Terumo Corporation: Product offering Scorecard
Figure 54 Terumo Corporation: Business Strategy Scorecard
Figure 55 Microport Scientific Corporation: Company Snapshot (2015)
Figure 56 Microport Scientific Corporation: Product offering Scorecard
Figure 57 Microport Scientific Corporation: Business Strategy Scorecard
Figure 58 Meril Life Sciences Pvt. Ltd: Product offering Scorecard
Figure 59 Meril Life Sciences Pvt. Ltd: Business Strategy Scorecard
Figure 60 Vascular Concepts Limited: Product offering Scorecard
Figure 61 Vascular Concepts Limited: Business Strategy Scorecard
Figure 62 C.R. Bard, Inc.: Company Snapshot (2016)
Figure 63 C.R. Bard: Product offering Scorecard
Figure 64 C.R. Bard: Business Strategy Scorecard
Figure 65 W. L. Gore & Associates, Inc.: Product offering Scorecard
Figure 66 W. L. Gore & Associates, Inc.: Business Strategy Scorecard
Figure 67 Endologix, Inc.: Company Snapshot (2016)
Figure 68 Endologix, Inc.: Product offering Scorecard
Figure 69 Endologix, Inc.: Business Strategy Scorecard
Figure 70 Lombard Medical: Company Snapshot (2015)
Figure 71 Lombard Medical: Product offering Scorecard
Figure 72 Lombard Medical: Business Strategy Scorecard
Figure 73 Translumina Gmbh: Product offering Scorecard
Figure 74 Translumina: Business Strategy Scorecard
Figure 75 Jotec Gmbh: Product offering Scorecard
Figure 76 Jotec Gmbh: Business Strategy Scorecard

【レポートのキーワード】

血管用ステント、ベアメタルステント、金属ステント、生体吸収性ステント、薬剤溶出ステント、ステント材料、ステンレスステント、PtCrステント、ニチノールステント

★調査レポート[血管ステントの世界市場予測(~2021年):ベアメタルステント、生体吸収性ステント、薬剤溶出ステント] ( Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021 / MAM-MD5228) 販売に関する免責事項
[血管ステントの世界市場予測(~2021年):ベアメタルステント、生体吸収性ステント、薬剤溶出ステント] ( Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021 / MAM-MD5228) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆